4:32 PM ET
8-K
Investor Presentation
Rafael Holdings Investor Presentation
Rafael Holdings filed a formal investor presentation deck (Exhibit 99.1) following its October 2026 NDA submission for remibetadex. The presentation highlights topline Phase 3 data in Niemann-Pick Disease Type C (NPC), including a prespecified analysis showing a 71% relative slowing of disease progression in a specific patient subgroup.